MedTrace Logo

Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness

NCT03881592 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-03-19

No results posted yet for this study

Summary

This study will be a secondary use of data, focusing on patients treated with combination therapy Obi-Clb, R-Clb or R-B, in a non-interventional, open label, national, multicenter setting. Retrospective analysis of data coming from registry database CLLEAR (www.leukemia-cell.org )that capture data on clinical and treatment practices in CLL. Data will be retrospectively analyzed.

Conditions

Sponsors & Collaborators

  • Brno University Hospital

    lead OTHER

Principal Investigators

  • Michael Doubek, Prof,MD,PhD · The Czech CLL Study Group

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-06-30
Completion
2019-09-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881592 on ClinicalTrials.gov